[
  {
    "title": "Recursion Pharmaceuticals (RXRX) Hits Clinical Milestones as 2025 Revenue Grows to $74.7M",
    "link": "https://finance.yahoo.com/news/recursion-pharmaceuticals-rxrx-hits-clinical-192714543.html",
    "publisher": "Insider Monkey",
    "date": "2026-02-26T19:27:14Z",
    "type": "STORY"
  },
  {
    "title": "Novavax shares subdued despite earnings, revenue beat",
    "link": "https://finance.yahoo.com/news/novavax-shares-subdued-despite-earnings-134600080.html",
    "publisher": "Investing.com",
    "date": "2026-02-26T13:46:00Z",
    "type": "STORY"
  },
  {
    "title": "Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk",
    "link": "https://www.marketbeat.com/instant-alerts/adagene-spotlights-adg126keytruda-data-late-line-mss-crc-focus-in-oppenheimer-conference-talk-2026-02-25/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "publisher": "MarketBeat",
    "date": "2026-02-25T22:25:39Z",
    "type": "STORY"
  },
  {
    "title": "Recursion Pharmaceuticals Q4 Earnings Call Highlights",
    "link": "https://www.marketbeat.com/instant-alerts/recursion-pharmaceuticals-q4-earnings-call-highlights-2026-02-25/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "publisher": "MarketBeat",
    "date": "2026-02-25T22:25:38Z",
    "type": "STORY"
  },
  {
    "title": "RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up",
    "link": "https://finance.yahoo.com/news/rxrx-q4-loss-narrower-expected-152100807.html",
    "publisher": "Zacks",
    "date": "2026-02-25T15:21:00Z",
    "type": "STORY"
  },
  {
    "title": "2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years",
    "link": "https://www.fool.com/investing/2026/02/24/reasons-regeneron-stock-crush-market-decade/",
    "publisher": "Motley Fool",
    "date": "2026-02-25T00:36:00Z",
    "type": "STORY"
  },
  {
    "title": "Should FDA Approval of Dupixent in AFRS Patients Prompt Action From Regeneron Pharmaceuticals (REGN) Investors?",
    "link": "https://finance.yahoo.com/news/fda-approval-dupixent-afrs-patients-231452990.html",
    "publisher": "Simply Wall St.",
    "date": "2026-02-24T23:14:52Z",
    "type": "STORY"
  },
  {
    "title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug",
    "link": "https://www.barrons.com/articles/vir-biotechnology-stock-earnings-prostate-cancer-drug-6ed19b80?siteid=yhoof2&yptr=yahoo",
    "publisher": "Barrons.com",
    "date": "2026-02-24T16:17:00Z",
    "type": "STORY"
  },
  {
    "title": "European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading",
    "link": "https://finance.yahoo.com/news/european-equities-traded-us-american-160320899.html",
    "publisher": "MT Newswires",
    "date": "2026-02-24T16:03:20Z",
    "type": "STORY"
  },
  {
    "title": "Sanofiâ€™s (SNY) R&D Track Record Remains Investor Concern, Says BofA",
    "link": "https://finance.yahoo.com/news/sanofi-sny-r-d-track-213046804.html",
    "publisher": "Insider Monkey",
    "date": "2026-02-23T21:30:46Z",
    "type": "STORY"
  }
]